Skip to main content

Latest stock market podcasts

Morning Bell 13 April

Bell Direct
April 13, 2021

Vaccine talks will dominate local headlines today for two reasons – the Federal government has taken the J&J vaccine off the table and ScoMo has said that Aussies will likely not receive a vaccine by the end of year.

 

This means travel and tourism stocks will be back in focus, in particular Qantas (ASX:QAN), as the company planned to initially resume international flights in October as Australians were initially set to be vaccinated by then.

 

What to watch today:  

  • The Aussie market is expected to rise 0.2% if the futures are correct.
  • New home sales and business confidence data out today.
  • Keep an eye on the most traded stocks from yesterday. For our active trader desk, Bell Direct Advantage they were: Delorean (ASX:DEL) which listed on the ASX on Monday, and Digital Wine Ventures (ASX:DW8).

 

Trading ideas:

  • The a2Milk Company (ASX:A2M) was upgraded from a Hold to a Buy with an increased price target of $9.50 as China distribution is showing strong signs of early life.
  • Macquarie rated Dexus (ASX:DXS) as a Buy with a $10.33 target and an estimated dividend yield of 4.53%.
  • Galan Lithium (ASX:GLN), Mach7 Technologies (ASX:M7T), People Infrastructure (ASX:PPE) are all giving off bullish charting signals according to Trading Central.

Weekly Wrap 14 February

Bell Direct
February 14, 2020

Morning Bell 14 February

Bell Direct
February 13, 2020

From the helm: Brickworks' Lindsay Partridge

Bell Direct
February 12, 2020

Morning Bell 11 February

Bell Direct
February 10, 2020

Morning Bell 10 February

Bell Direct
February 9, 2020

Weekly Wrap 7 February

Bell Direct
February 7, 2020

Morning Bell 7 February

Bell Direct
February 6, 2020

Morning Bell 6 February

Bell Direct
February 5, 2020

Morning Bell 5 February

Bell Direct
February 4, 2020

Reporting season: Temple & Webster results

Bell Direct
February 4, 2020

Morning Bell 4 February

Bell Direct
February 3, 2020